GenVec Inc. (GNVC)
Symbol Info
Listed Symbol GNVC
Name GenVec Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2016-12-31
Latest Fiscal Revenue $511,000
Latest Fiscal EPS $-2.86
Price Info
21 Day Moving Average $6.9086
21 Day EMA $6.997600
50 Day Moving Average $6.6797
50 Day EMA $6.750530
200 Day EMA $6.397800
200 Day Moving Average 5.383630
52 Week High $10.44
52 Week Low $2.70
52 Week Change $18.833600
Alpha 0.018230
Beta 3.5331
Standard Deviation 0.552564
R2 0.030884
Periods 60
Share Information
10 Day Average Volume 6,081
20 Day Average Volume 4,993
30 Day Average Volume 12,049
50 Day Average Volume 22,561
Outstanding Shares 2,273,632
Float Shares 1,056,079
Percent Float 46.45%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 9
Institute Holdings Date 2017-03-31
Institute Bought Previous 3 Months 124,929
Institute Holdings Percent 13.100000
Institute Sold Previous 3 Months 19,650
Insider Holdings Date 2017-05-31
Insider Bought Previous 3 Months 21,987
Insider Holdings Percent 53.60%
Insider Sold Previous 3 Months -
Insiders Shares Owned 1,217,553
Price Change
7 Day Price Change $-
7 Day Percent Change -
21 Day Price Change $0.6029997
21 Day Percent Change 9.15%
30 Day Price Change $0.2929997
30 Day Percent Change 4.25%
Month To Date Price Change $0.7630
Month To Date Percent 11.87%
90 Day Price Change $1.193000
90 Day Percent Change 19.88%
Quarter To Date $1.133000
Quarter To Date Percent 18.70%
180 Day Price Change $3.913000
180 Day Percent Change 119.30%
200 Day Price Change $4.233000
200 Day Percent Change 143.01%
Year To Date $3.983000
Year To Date Percent 124.08%
Profile
Description Genvec Inc was incorporated under the laws of the state of Delaware on December 7, 1992.The Company is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. Its development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus or RSV, herpes simplex virus or HSV, and malaria. In the area of animal health the Company is developing vaccines against foot-and-mouth disease or FMD. In collaboration with Novartis, the Companys hearing and balance disorders program is focused on the restoration of hearing and balance function through the regeneration of critical cells of the inner ear.
Details
Issue Type CS
Market Cap $16,354,235
Sec Type EQS
Auditor Dixon Hughes Goodman LLP
Total Shares Outstanding -
CEO Douglas J. Swirsky
Employees 15
Last Audit UE
Classification
CIK 0000934473
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 910 Clopper Road
Suite 220N
Gaithersburg, MD 20878
Website http://www.genvec.com
Facisimile +1 240 632-0735
Telephone +1 240 632-0740
Email dswirsky@GENVEC.com
Key Ratios
Profitability
EBIT Margin -2,085.1
EBITDA Margin -2,059.1
Pre-Tax Profit Margin -467.2
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $335,000
Revenue Per Share $0.1473
Revenue 3 Years $-56.89
Revenue 5 Years $-49.33
Valuation Measures
PE Ratio -
Enterprise Value $12,069,234
Price To Sales 48.818610
Price To Free Cash -2.3
PE High Last 5 Years -
Price To Book 28.1
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 28.1
Financial Strength
Total Debt To Equity -
Int Coverage -31.8
Current Ratio 2.1
Leverage Ratio 1.8
Quick Ratio 2.0
Long Term Debt To Capital -
Assets
Receivables Turnover 0.7
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets -130.65
Return On Equity -248.11
Return On Capital -248.11
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
GNVC
Genvec, In..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.